A Turning Point in Pancreatic Cancer Care: NCCN Embraces Precision Medicine

April 10, 2026

Precede Foundation

A major shift in pancreatic cancer care is here, and it’s bringing us closer to truly personalized treatment for every patient.

The latest update from the National Comprehensive Cancer Network (NCCN) strengthens its recommendation for comprehensive molecular profiling, including next-generation sequencing (NGS) and RNA sequencing. This marks an important step toward making precision medicine a standard part of pancreatic cancer care.

Why This Matters

Pancreatic cancer has historically been treated with a one-size-fits-all approach. But tumors are biologically unique, and those differences can significantly impact treatment outcomes.

With broader use of NGS and RNA sequencing, clinicians can now identify specific genetic alterations that may open the door to:

Targeted therapies
Clinical trials
More personalized treatment plans

For some patients, this testing can reveal options that would have otherwise gone undiscovered.

From Recommendation to Standard Practice

While molecular testing has been discussed for years, it hasn’t always been consistently used. The updated NCCN guidelines help change that by reinforcing and standardizing tumor profiling as a key part of care, especially for patients with advanced disease.

This means fewer missed opportunities and more patients gaining access to potentially life-changing insights.

A Step Toward Precision Medicine for All

The inclusion of both DNA (NGS) and RNA sequencing reflects a growing shift toward a more complete, data-driven understanding of cancer. This multimodal approach helps ensure that treatment decisions are based on each patient’s unique biology, not just generalized assumptions.

What Patients Should Know

For patients and families, the takeaway is simple: comprehensive testing matters.

It can:

Identify new treatment options
Inform better care decisions
Support a more personalized approach to treatment

As you explore testing options, it’s also important to check with your insurance provider to determine whether next-generation sequencing (NGS) and RNA testing are covered under your specific plan. Understanding your benefits in advance can help avoid unexpected costs and ensure access to the care you need.

Looking Ahead

Pancreatic cancer remains one of the most challenging cancers to treat, but updates like this signal real progress.

By aligning clinical guidelines with advances in precision medicine, the NCCN is helping move us toward a future where every patient receives care tailored to their specific disease.

And that future is getting closer.

Knowing When To Ask For Help

There’s strength in recognizing when you need additional support. If you’re feeling consistently overwhelmed, anxious, or depressed, it may be time to speak with a healthcare professional. Warning signs can include ongoing sleep trouble, loss of appetite, or emotional numbness.

Mental health care is an important part of cancer recovery. There are therapists, social workers, and cancer-specific counselors trained to support your unique needs. Don’t hesitate to seek them out.

Your medical team can help adjust medications or recommend physical therapy if your symptoms are impacting your daily life. Being honest about your struggles allows your care providers to offer better, more personalized support.

The path to recovery from pancreatic cancer is rarely straightforward. It’s a mix of triumphs and setbacks, strength and vulnerability. But through each high and low, healing is happening. Be gentle with yourself. Allow space for rest, reflection, and growth.

You don’t have to go through this journey alone. With the right support, emotional, physical, and practical, you can move forward, one step at a time. And remember, every day you show up for yourself is a victory.

At TrovaNOW, we’re focused on finding a cure for pancreatic cancer. Every test and discovery brings us closer to better treatments and saving lives. Join us and learn more at TrovaNOW.